EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]

ProMIS Neurosciences has reported the first human evidence that its [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

The first patients have been dosed with MP0712, a DLL3-targeted [...]

Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

Absci has reported positive interim Phase 1 data for ABS-201, [...]

bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]